Author name: Danesh Alam MD, DFAPA, DFASAM

Dr. Alam is an internationally renowned psychiatrist with academic affiliations with Northwestern University and University of Illinois, Chicago where he completed his residency training. He has been a principal investigator for over forty studies and has been involved in research leading to the approval of most psychiatric medications currently on the market. He is the founder of the Neuroscience Research Institute which continues to conduct research on cutting edge medication and interventional psychiatry. Dr. Alam is a Distinguished Fellow of the American Psychiatric Association and the American Society of Addiction Medicine. He has won several awards and has been featured extensively on radio and television.

Ambrosia Announces Groundbreaking MAT Study

Ambrosia Announces Groundbreaking MAT Study Read More »

In partnership with Nova Southeastern University, Ambrosia will conduct a study on Gabapentin, a controversial medication used in addiction treatment. For the first time, a groundbreaking new study is going to be conducted at a national treatment center. Ambrosia Treatment Center announced this month that they have been selected by Nova Southeastern University to participate

Ambrosia Announces 19k Square-Foot Expansion in South New Jersey

Ambrosia Announces 19k Square-Foot Expansion in South New Jersey Read More »

Press Release:  Ambrosia Treatment Center has completed construction of a new center, an expansion of their existing Southern New Jersey Campus. The project adds more quality addiction treatment in the Greater Philadelphia area in response to the growing epidemic in the Northeast. This spring, Ambrosia Treatment Center will expand its Medford, New Jersey campus with a
Scroll to Top